Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carol R Gleason

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Pharmacological and Toxicological Methods|July 22, 2006
Novel probabilistic method for precisely correcting the QT interval for heart rate in telemetered dogs and cynomolgus monkeysHenry H Holzgrefe, Icilio Cavero, Carol R Gleason, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 9, 2021
Thymic Lymphomas in a 6-Month rasH2-Tg Mouse Carcinogenicity Study With the RORγt Inverse Agonist, BMS-986251Helen G Haggerty, Jean G Sathish, Carol R Gleason, et al.
The AAPS Journal|May 1, 2015
Development and Fit-for-Purpose Validation of a Soluble Human Programmed Death-1 Protein AssayYan G Ni, Xiling Yuan, John A Newitt, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Pharmacological and Toxicological Methods|July 22, 2006
Novel probabilistic method for precisely correcting the QT interval for heart rate in telemetered dogs and cynomolgus monkeysHenry H Holzgrefe, Icilio Cavero, Carol R Gleason, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 9, 2021
Thymic Lymphomas in a 6-Month rasH2-Tg Mouse Carcinogenicity Study With the RORγt Inverse Agonist, BMS-986251Helen G Haggerty, Jean G Sathish, Carol R Gleason, et al.
The AAPS Journal|May 1, 2015
Development and Fit-for-Purpose Validation of a Soluble Human Programmed Death-1 Protein AssayYan G Ni, Xiling Yuan, John A Newitt, et al.
Pageof 2